Clinical Trial: A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07465263) titled 'A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)' on March 06.

Brief Summary: Heterozygous Familial Hypercholesterolemia (HeFH) is an autosomal dominant disorder characterized by markedly elevated low-density lipoprotein cholesterol (LDL-C) and increased risk of atherosclerotic cardiovascular disease (ASCVD). This trial aims to evaluate the SYH2053 Injection in patients with HeFH.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Heterozygous Familial Hypercholesterolemia (HeFH)

Intervention: DRUG: SYH2053 Injection

Administered by subcutaneous inject...